fundvisualizer.com

Aspiriant Risk-Managed Equity Allc AdvRMEAX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2023
Stock
50.19%
Non-U.S. Stock
30.14%
Bond
0.54%
Non-U.S. Bond
0.00%
Preferred
0.07%
Convertible
0.00%
Cash
1.74%
Other
17.31%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2023

Basic materials

0.35%

Consumer cyclical

2.28%

Financial services

2.43%

Real estate

0.34%

Consumer defensive

1.80%

Health care

4.49%

Utilities

0.04%

Communication services

2.03%

Energy

0.21%

Industrials

2.24%

Technology

6.83%

Top 10 holdings

As of 12/31/2023

GMO Quality VI
29.18%
iShares MSCI Global Min Vol Factor ETF
9.99%
RIEF STRATEGIC PARTNERS FUND
8.86%
Schwab Fundamental Emerg Mkts Lg Co ETF
7.49%
Gmo Investments Icav - Gmo Equity Dislocation
6.41%
Baillie Gifford Emerging Markets Eqs K
6.08%
AQR Large Cap Defensive Style R6
5.86%
BRIDGEWATER ALL WEATHER CHINA, LTD.
1.85%
JPMorgan Prime Money Market Morgan
1.26%
Microsoft Corp
1.21%
Fund assets

$1.4 Billion

Share class

Adv

Morningstar category

Global Large-Stock Blend

Expense ratio

0.79%

Investment objective

World Stock

Documents